Study To Evaluate Safety, Tolerability, and Pharmacokinetics of MAM01 in African Population
Clinical trial NCT06408857 · COMPLETED
Trial details
- NCT number
- NCT06408857
- Sponsor
- Gates Medical Research Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-28
- Primary completion
- 2026-05-28
- Enrollment
- 125
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.